Advanced search
Start date

Synthesis of molecular hybrids derived from 4-quinolones as potential drug candidates to treat Alzheimer's Disease

Grant number: 13/18203-5
Support Opportunities:Regular Research Grants
Duration: December 01, 2013 - February 29, 2016
Field of knowledge:Health Sciences - Pharmacy
Principal Investigator:Wanda Pereira Almeida
Grantee:Wanda Pereira Almeida
Host Institution: Instituto de Química (IQ). Universidade Estadual de Campinas (UNICAMP). Campinas , SP, Brazil


The aim of this project is to identify potential drug candidates to treat Alzheimer´s disease (AD). In this way, we propose the synthesis of a series of N-acylhydrazone and piperazine derivatives of 3-carboethoxy-4-quinolone, as well the evaluation of their effects on the acetylcholinesterase (AChE) activity and aggregation of the beta-amyloid peptide, an important biomarker of AD. Our purpose is based on previous studies performed by our research group, which demonstrated that the cited quinolone inhibits the beta-amyloid aggregation and has a moderate effect on the AChE activity. Piperazine derivatives have a structural moiety smilar to donepezil, a known AChE inhibitor. In this drug, the mentioned subunit binds to the catalytic site of the enzyme. Regarding N-acylhydrazone derivatives, the hydrazone group is able to chelate metals and is part of several bioactive compounds. The activity of these compounds is related to the presence of N-acyl-hydrazone portion. Our synthetic strategy relies on a short step sequence, which has been employed in our laboratory to prepare a sort of substituted 4-quinolones. The biological evaluations will be done by following well-established protocols in the literature and in our research group. (AU)

Articles published in Agência FAPESP Newsletter about the research grant:
Articles published in other media outlets (0 total):
More itemsLess items

Scientific publications (4)
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
GOMES, RALPH C.; SAKATA, RENATA P.; ALMEIDA, WANDA P.; COELHO, FERNANDO. Spirocyclohexadienones as an Uncommon Scaffold for Acetylcholinesterase Inhibitory Activity. Medicinal Chemistry, v. 15, n. 4, p. 373-382, . (13/10449-5, 13/18203-5)
DANIELA P. GOUVÊA; GABRIELE A. BERWALDT; PATRÍCIA D. NEUENFELDT; RICARDO J. NUNES; WANDA P. ALMEIDA; WILSON CUNICO. Synthesis of Novel 2-Aryl-3-(2-morpholinoethyl)-1,3-thiazinan-4-ones Via Ultrasound Irradiation. Journal of the Brazilian Chemical Society, v. 27, n. 6, p. 1109-1115, . (13/18203-5)
SAKATA, RENATA P.; FIGUEIRO, MICHELI; KAWANO, DANIEL F.; ALMEIDA, WANDA P.. Effect on Acetylcholinesterase and Anti-oxidant Activity of Synthetic Chalcones having a Good Predicted Pharmacokinetic Profile. Medicinal Chemistry, v. 13, n. 7, p. 654-663, . (13/18203-5)
DA SILVA, GISELE S.; FIGUEIRO, MICHELI; TORMENA, CLAUDIO F.; COELHO, FERNANDO; ALMEIDA, WANDA P.. Effects of novel acylhydrazones derived from 4-quinolone on the acetylcholinesterase activity and A beta 42 peptide fibrils formation. Journal of Enzyme Inhibition and Medicinal Chemistry, v. 31, n. 6, p. 1464-1470, . (13/18203-5)

Please report errors in scientific publications list by writing to: